Araştırma Makalesi
BibTex RIS Kaynak Göster

Re-probing Causes in Congenital Nasolacrimal Duct Obstructions

Yıl 2021, Cilt: 16 Sayı: 1, 7 - 11, 08.02.2021
https://doi.org/10.17517/ksutfd.813607

Öz

Objective: It was aimed to show the factors leading to failure of first probing, necessitating second probing application.
Materials and Methods: In this retrospective case series, patients diagnosed with congenital nasolacrimal duct obstruction (CNLDO) between January 2010 and December 2019 and treated with a nasolacrimal duct (NLD) probe were included. The files of patients diagnosed with CNLDO and treated with NLD probing between these years at XX University were reviewed. Patients characteristics including sex, age, consultation notes, operation records, re-probing number and existence of systemic disease were recorded.
Results: A total of 110 patients were recruited into the study finally. The mean age of patients was 17.55±5.40 (9-34) months and 46 female (41.8%), 64 male (58.2%). While the ninety three patients (84.5%) showing improvement of symptoms after the first probing considered successful, 17 patients (15.5%) having smilar symptoms regarded failed probing. Grouping patients with age less than ≤18 months or more had similar success rates with regard to probing success (p=0.250). No difference in success rate was found for gender (p=0.953) and laterality (p=0.116). Local diseases (nasal cavity problems, canalicular narrowing, anatomical variation etc.) were detected in 14 patients, who have been planned for secondary probing.
Conclusion: Our study is in congruity with other studies claiming no effect of sex, age or laterality on probing success. If first probing fails, a thorough management plan including also exploration and handling of reasons underlying the first failure should be implemented before second probing.

Kaynakça

  • 1. Olitsky SE. Update on congenital nasolacrimal duct obstruction. Int Ophthalmol Clin. 2014;54(3):1-7.
  • 2. Takahashi Y, Kakizaki H, Chan WO, Selva D. Management of congenital nasolacrimal duct obstruction. Acta Ophthalmol. 2010;88(5):506-13.
  • 3. Avram E. Insights in the treatment of congenital nasolacrimal duct obstruction. Rom J Ophthalmol. 2017;61(2):101-6.
  • 4. Karti O, Karahan E, Acan D, Kusbeci T. The natural process of congenital nasolacrimal duct obstruction and effect of lacrimal sac massage. Int Ophthalmol. 2016;36(6):845-9.
  • 5. Vagge A, FerroDesideri L, Nucci P, Serafino M, Giannaccare G, Lembo A, et al. Congenital Nasolacrimal Duct Obstruction (CNLDO): A Review. Diseases. 2018;6(4):96.
  • 6. Tai ELM, Kueh YC, Abdullah B. The Use of Stents in Children with Nasolacrimal Duct Obstruction Requiring Surgical Intervention: A Systematic Review. Int J Environ Res Public Health. 2020;17(3):1067.
  • 7. Rahim S, Nanda R, Gupta D. Result of Probing for Congenital Nasolacrimal Duct Obstruction in Children Less than 1 Year Versus Children Greater than 1 Year. JK Science. 2019;21(4):156-9.
  • 8. Perveen S, Sufi AR, Rashid S, Khan A. Success rate of probing for congenital nasolacrimal duct obstruction at variousages. J Ophthalmic Vis Res. 2014;9(1):60-9.
  • 9. Rajabi MT, Abrishami Y, Hosseini SS, Tabatabaee SZ, Rajabi MB, Hurwitz JJ. Success rate of late primary probing in congenital nasolacrimal duct obstruction. J Pediatr Ophthalmol Strabismus. 2014;51(6):360-2.
  • 10. Yılmaz T, Yılmaz A, Kırgız A, Taskapılı M. The efficacy and safety of probing as a treatment procedure for congenital nasolacrimal duct obstruction. Istanbul Med J. 2013;14(3):191-4.
  • 11. Ali MJ, Kamal S, Gupta A, Ali MH, Naik MN. Simple vs complex congenital nasolacrimal duct obstructions: etiology, management and outcomes. Int Forum Allergy Rhinol. 2015;5(2):174-7.
  • 12. Une VL, Kulkarni SS, Nandedkar VS. Effect of Probing in Congenital Nasolacrimal Duct Obstruction in Children Older Than 2 Years. J Pediatr Ophthalmol Strabismus. 2019;56(3):141-5.
  • 13. Valcheva KP, Murgova SV, Krivoshiiska EK. Success Rate of Probing for Congenital Nasolacrimal Duct Obstruction in Children. Folia Med (Plovdiv). 2019;61(1):97-103.
  • 14. Napier ML, Armstrong DJ, McLoone SF, McLoone EM. Congenital Nasolacrimal Duct Obstruction: Comparison of Two Different Treatment Algorithms. J Pediatr Ophthalmol Strabismus. 2016;53(5):285-91.
  • 15. Beato J, Mota, Á, Gonçalves, N, Santos-Silva R, Magalhaes A, Breda J, et al. Factors Predictive of Success in Probing for Congenital Nasolacrimal Duct Obstruction. J Pediatr Ophthalmol Strabismus. 2017;54(2):123-7.
  • 16. Petris C, Liu D. Probing for congenital nasolacrimal duct obstruction. Cochrane Database Syst Rev. 2017;7(7):CD011109.
  • 17. Hung CH, Chen YC, Lin SL, Chen WL. Nasolacrimal Duct Probing under Topical Anesthesia for Congenital Nasolacrimal Duct Obstruction in Taiwan. Pediatr Neonatol. 2015;56(6):402-7.
  • 18. Xiang Q, Gao X, Chen X, Qi J, Fang J. Nasolacrimal Duct Probing for Young Children With Congenital Nasolacrimal Duct Obstructions in China: A 10-Year Systematic Review. J Pediatr Ophthalmol Strabismus. 2019;56(6):365-72.

Konjenital Nazolakrimal Kanal Tıkanıklıklarında Yeniden-problama Nedenlerinin Araştırılması

Yıl 2021, Cilt: 16 Sayı: 1, 7 - 11, 08.02.2021
https://doi.org/10.17517/ksutfd.813607

Öz

Amaç: İlk problamanın başarısız olmasına neden olan ikinci problama uygulamasını gerektiren faktörlerin gösterilmesi amaçlanmıştır.
Gereç ve yöntemler: Bu Retrospektif vaka serisine, Ocak 2010 ile Aralık 2019 arasındaki Konjenital nazolakrimal kanal tıkanıklığı (KNLKT) tanısı alan ve nazolakrimal kanal (NLK) sondası ile tedavi edilen hastalar dahil edildi. XX Üniversitesi'nde bu yıllar arasında KNLKT tanısı alan ve NLK sondası ile tedavi edilen hastaların dosyaları incelendi. Hastaların cinsiyet, yaş, konsültasyon notları, operasyon kayıtları, yeniden probing uygulama sayıları ve sistemik hastalık varlığı gibi özellikleri kaydedildi.
Bulgular: Çalışmaya toplam 110 hasta alındı. Hastaların yaş ortalaması 17,55±5,40 (9-34) ay ve 46 kadın (% 41,8), 64 erkek (% 58,2) idi. İlk probing sonrası semptomlarda düzelme gösteren 93 hasta (% 84.5) başarılı kabul edilirken, benzer semptomları olan 17 hastada (% 15.5) probingin başarısız olduğu kabul edildi. Yaşı 18 aydan küçük veya daha büyük olan hastaların gruplandırılması, araştırma başarısı açısından benzer başarı oranlarına sahipti (p=0,250). Cinsiyet (p=0,953) ve lateralite bakımından başarı oranında fark bulunamadı (p=0,116). Sekonder sondalama planlanan 14 hastada lokal hastalıklar (burun boşluğu sorunları, kanaliküler daralma, anatomik varyasyon vs.) tespit edildi.
Sonuç: Çalışmamız, cinsiyet, yaş veya lateralitenin araştırmanın başarısı üzerinde hiçbir etkisi olmadığını öne süren diğer çalışmalarla uyumludur. İlk araştırma başarısız olursa, ilk hatanın altında yatan nedenlerin ele alınması ve araştırılmasını da içeren kapsamlı bir yönetim planı, ikinci araştırmadan önce uygulanmalıdır.

Kaynakça

  • 1. Olitsky SE. Update on congenital nasolacrimal duct obstruction. Int Ophthalmol Clin. 2014;54(3):1-7.
  • 2. Takahashi Y, Kakizaki H, Chan WO, Selva D. Management of congenital nasolacrimal duct obstruction. Acta Ophthalmol. 2010;88(5):506-13.
  • 3. Avram E. Insights in the treatment of congenital nasolacrimal duct obstruction. Rom J Ophthalmol. 2017;61(2):101-6.
  • 4. Karti O, Karahan E, Acan D, Kusbeci T. The natural process of congenital nasolacrimal duct obstruction and effect of lacrimal sac massage. Int Ophthalmol. 2016;36(6):845-9.
  • 5. Vagge A, FerroDesideri L, Nucci P, Serafino M, Giannaccare G, Lembo A, et al. Congenital Nasolacrimal Duct Obstruction (CNLDO): A Review. Diseases. 2018;6(4):96.
  • 6. Tai ELM, Kueh YC, Abdullah B. The Use of Stents in Children with Nasolacrimal Duct Obstruction Requiring Surgical Intervention: A Systematic Review. Int J Environ Res Public Health. 2020;17(3):1067.
  • 7. Rahim S, Nanda R, Gupta D. Result of Probing for Congenital Nasolacrimal Duct Obstruction in Children Less than 1 Year Versus Children Greater than 1 Year. JK Science. 2019;21(4):156-9.
  • 8. Perveen S, Sufi AR, Rashid S, Khan A. Success rate of probing for congenital nasolacrimal duct obstruction at variousages. J Ophthalmic Vis Res. 2014;9(1):60-9.
  • 9. Rajabi MT, Abrishami Y, Hosseini SS, Tabatabaee SZ, Rajabi MB, Hurwitz JJ. Success rate of late primary probing in congenital nasolacrimal duct obstruction. J Pediatr Ophthalmol Strabismus. 2014;51(6):360-2.
  • 10. Yılmaz T, Yılmaz A, Kırgız A, Taskapılı M. The efficacy and safety of probing as a treatment procedure for congenital nasolacrimal duct obstruction. Istanbul Med J. 2013;14(3):191-4.
  • 11. Ali MJ, Kamal S, Gupta A, Ali MH, Naik MN. Simple vs complex congenital nasolacrimal duct obstructions: etiology, management and outcomes. Int Forum Allergy Rhinol. 2015;5(2):174-7.
  • 12. Une VL, Kulkarni SS, Nandedkar VS. Effect of Probing in Congenital Nasolacrimal Duct Obstruction in Children Older Than 2 Years. J Pediatr Ophthalmol Strabismus. 2019;56(3):141-5.
  • 13. Valcheva KP, Murgova SV, Krivoshiiska EK. Success Rate of Probing for Congenital Nasolacrimal Duct Obstruction in Children. Folia Med (Plovdiv). 2019;61(1):97-103.
  • 14. Napier ML, Armstrong DJ, McLoone SF, McLoone EM. Congenital Nasolacrimal Duct Obstruction: Comparison of Two Different Treatment Algorithms. J Pediatr Ophthalmol Strabismus. 2016;53(5):285-91.
  • 15. Beato J, Mota, Á, Gonçalves, N, Santos-Silva R, Magalhaes A, Breda J, et al. Factors Predictive of Success in Probing for Congenital Nasolacrimal Duct Obstruction. J Pediatr Ophthalmol Strabismus. 2017;54(2):123-7.
  • 16. Petris C, Liu D. Probing for congenital nasolacrimal duct obstruction. Cochrane Database Syst Rev. 2017;7(7):CD011109.
  • 17. Hung CH, Chen YC, Lin SL, Chen WL. Nasolacrimal Duct Probing under Topical Anesthesia for Congenital Nasolacrimal Duct Obstruction in Taiwan. Pediatr Neonatol. 2015;56(6):402-7.
  • 18. Xiang Q, Gao X, Chen X, Qi J, Fang J. Nasolacrimal Duct Probing for Young Children With Congenital Nasolacrimal Duct Obstructions in China: A 10-Year Systematic Review. J Pediatr Ophthalmol Strabismus. 2019;56(6):365-72.
Toplam 18 adet kaynakça vardır.

Ayrıntılar

Birincil Dil İngilizce
Konular Sağlık Kurumları Yönetimi
Bölüm Araştırma Makaleleri
Yazarlar

Selma Urfalıoglu 0000-0002-3709-6988

Gökhan Özdemir 0000-0002-0257-9883

Mete Güler 0000-0002-6232-8445

Gamze Duman Bu kişi benim 0000-0001-8690-7436

İsmail Evgin 0000-0001-9142-2505

Feyza Çalışır 0000-0002-8882-4666

Yayımlanma Tarihi 8 Şubat 2021
Gönderilme Tarihi 20 Ekim 2020
Kabul Tarihi 25 Kasım 2020
Yayımlandığı Sayı Yıl 2021 Cilt: 16 Sayı: 1

Kaynak Göster

AMA Urfalıoglu S, Özdemir G, Güler M, Duman G, Evgin İ, Çalışır F. Re-probing Causes in Congenital Nasolacrimal Duct Obstructions. KSÜ Tıp Fak Der. Şubat 2021;16(1):7-11. doi:10.17517/ksutfd.813607